Michael K. Haseman

1.4k total citations
27 papers, 1.0k citations indexed

About

Michael K. Haseman is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Michael K. Haseman has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Surgery. Recurrent topics in Michael K. Haseman's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Michael K. Haseman is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Michael K. Haseman collaborates with scholars based in United States and Canada. Michael K. Haseman's co-authors include Thomas R. Pounds, Peter E. Valk, Donald M. Hopkins, Seth A. Rosenthal, Daniel Kahn, Richard Myers, Michael J. Manyak, Calvin L. Lutrin, Robert T. Maguire and Thomas J. Polascik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Radiology.

In The Last Decade

Michael K. Haseman

25 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael K. Haseman United States 13 700 588 170 110 86 27 1.0k
Paul F. Schellhammer United States 8 712 1.0× 308 0.5× 157 0.9× 109 1.0× 182 2.1× 11 923
Paola Mapelli Italy 21 593 0.8× 630 1.1× 282 1.7× 105 1.0× 75 0.9× 89 1.2k
Kyu H. Shin United States 14 478 0.7× 156 0.3× 160 0.9× 87 0.8× 67 0.8× 34 921
Christopher D. Koprowski United States 13 717 1.0× 309 0.5× 354 2.1× 136 1.2× 61 0.7× 31 1.1k
Hansjörg Vees Switzerland 16 657 0.9× 492 0.8× 283 1.7× 100 0.9× 21 0.2× 30 1.1k
Paul Cane United Kingdom 16 1.2k 1.7× 491 0.8× 219 1.3× 122 1.1× 86 1.0× 36 1.4k
Thabo Lengana South Africa 15 795 1.1× 802 1.4× 336 2.0× 83 0.8× 63 0.7× 32 1.1k
Manabu Oguchi Japan 13 869 1.2× 790 1.3× 166 1.0× 77 0.7× 166 1.9× 31 1.3k
Maurits Wondergem Netherlands 16 729 1.0× 576 1.0× 175 1.0× 202 1.8× 26 0.3× 63 1.1k
Shinroku Morita Japan 18 877 1.3× 297 0.5× 206 1.2× 223 2.0× 123 1.4× 36 1.4k

Countries citing papers authored by Michael K. Haseman

Since Specialization
Citations

This map shows the geographic impact of Michael K. Haseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Haseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Haseman more than expected).

Fields of papers citing papers by Michael K. Haseman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Haseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Haseman. The network helps show where Michael K. Haseman may publish in the future.

Co-authorship network of co-authors of Michael K. Haseman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Haseman. A scholar is included among the top collaborators of Michael K. Haseman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Haseman. Michael K. Haseman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Haseman, Michael K., et al.. (2006). 16.08. Journal of Nuclear Cardiology. 13(4). S14–S15. 3 indexed citations
3.
Freeman, LM, et al.. (2002). The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancer.. PubMed. 46(2). 131–7. 16 indexed citations
4.
Stauffer, Edouard, et al.. (2001). Surgical confirmation of ProstaScint abnormalities in two patients with high risk prostate cancer.. PubMed. 8(1). 1199–202. 6 indexed citations
5.
Haseman, Michael K., Seth A. Rosenthal, & Thomas J. Polascik. (2000). Capromab Pendetide Imaging of Prostate Cancer. Cancer Biotherapy and Radiopharmaceuticals. 15(2). 131–140. 44 indexed citations
6.
Polascik, Thomas J., Michael J. Manyak, Michael K. Haseman, et al.. (1999). Comparison of clinical staging algorithms and111Indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. Cancer. 85(7). 1586–1592. 79 indexed citations
7.
8.
9.
Kahn, Daniel, Richard D. Williams, Michael J. Manyak, et al.. (1998). (111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 2041–2046.
10.
Kahn, Daniel, Richard D. Williams, Michael J. Manyak, et al.. (1998). (111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 2047–2047.
11.
Haseman, Michael K., et al.. (1996). Monoclonal Antibody Imaging of Occult Prostate Cancer in Patients With Elevated Prostate-Specific Antigen. Clinical Nuclear Medicine. 21(9). 704–713. 68 indexed citations
12.
Valk, Peter E., et al.. (1996). Cost-effectiveness of PET imaging in clinical oncology. Nuclear Medicine and Biology. 23(6). 737–743. 138 indexed citations
13.
Krag, David N., Michael K. Haseman, Patrick V. Ford, et al.. (1992). Gamma probe location of 111 indium‐labeled B72.3: An extension of immunoscintigraphy. Journal of Surgical Oncology. 51(4). 226–230. 16 indexed citations
14.
Morgan, Carys, et al.. (1992). Color flow-guided repair of axillary artery pseudoaneurysm. Journal of Ultrasound in Medicine. 11(11). 625–626. 2 indexed citations
15.
Haseman, Michael K., et al.. (1992). Radioimmunodetection of occult carcinoembryonic antigen-producing cancer.. PubMed. 33(10). 1750–6. 26 indexed citations
16.
Haseman, Michael K. & Joseph P. Kriss. (1985). Selective, Symmetric, Skeletal Muscle Uptake of Tc-99m Pyrophosphate in Rhabdomyolysis. Clinical Nuclear Medicine. 10(3). 180–183. 12 indexed citations
17.
Haseman, Michael K., David A. Goodwin, Claude F. Meares, et al.. (1984). METABOLIZABLE IN-111 CHELATE CONJUGATED ANTI-IDIOTYPE MONOCLONAL ANTIBODY FOR RADIOIMMUNODETECTION OF LYMPHOMA IN MICE. Clinical Nuclear Medicine. 9(Supplement 9). 39–39. 3 indexed citations
18.
Haseman, Michael K. & David A. Goodwin. (1983). Sequential lndium-111 Leukocyte Imaging in a Patient with Ulcerative Colitis. Clinical Nuclear Medicine. 8(8). 375–376. 2 indexed citations
19.
Haseman, Michael K.. (1982). Potential Pitfalls in the Interpretation of Erythrocyte Scintigraphy for Gastrointestinal Hemorrhage. Clinical Nuclear Medicine. 7(7). 309–310. 3 indexed citations
20.
Hawkins, Irvin F., et al.. (1979). Single Mini-Catheter Technique for Abdominal Aortography and Selective Injection. Radiology. 132(3). 755–757. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul F. Schellhammer Breakdown of academic impact, for papers by Paola Mapelli Breakdown of academic impact, for papers by Kyu H. Shin Breakdown of academic impact, for papers by Christopher D. Koprowski Breakdown of academic impact, for papers by Hansjörg Vees Breakdown of academic impact, for papers by Paul Cane Breakdown of academic impact, for papers by Thabo Lengana Breakdown of academic impact, for papers by Manabu Oguchi Breakdown of academic impact, for papers by Maurits Wondergem Breakdown of academic impact, for papers by Shinroku Morita
Rankless by CCL
2026